
pmid: 1348352
AbstractA variety of hyperkinetic movement disorders has been associated with the use of neuroleptics (dopamine receptor blocking drugs), but tardive tremor has not been previously documented. We describe five patients in whom tremor occurred after chronic treatment with neuroleptics, was aggravated by and persisted after neuroleptic withdrawal, and improved after treatment with the dopamine depleting drug tetrabenazine. This involuntary oscillatory movement, with a frequency range of 3–5 Hz, was most prominent during maintenance of a posture, but was also present at rest and during a goal‐directed movement. The tremor was accompanied by other tardive movement disorders, including akathisia, chorea, dystonia, myoclonus, and stereotypy. There was no family history or other explanation for tremor in these patients. We suggest that this hitherto unreported movement disorder is best termed “tardive tremor”.
Neurologic Examination, Dyskinesia, Drug-Induced, Dose-Response Relationship, Drug, Tetrabenazine, Tremor, Humans, Female, Middle Aged, Aged, Antipsychotic Agents
Neurologic Examination, Dyskinesia, Drug-Induced, Dose-Response Relationship, Drug, Tetrabenazine, Tremor, Humans, Female, Middle Aged, Aged, Antipsychotic Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 111 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
